Geron Corporation (GERN)
USD 1.3
(-6.16%)
USD 1.3
(-6.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -123.5 Million USD | -192.65% |
| 2022 | -272 Thousand USD | -144.59% |
| 2021 | 610 Thousand USD | 101.22% |
| 2020 | -49.79 Million USD | 1.99% |
| 2019 | -50.81 Million USD | -335.89% |
| 2018 | -11.65 Million USD | -58.13% |
| 2017 | -7.37 Million USD | 13.61% |
| 2016 | -8.53 Million USD | -131.84% |
| 2015 | 26.79 Million USD | 445.86% |
| 2014 | -7.74 Million USD | 1.31% |
| 2013 | -7.85 Million USD | 65.06% |
| 2012 | -22.46 Million USD | -1021.62% |
| 2011 | 2.43 Million USD | -31.57% |
| 2010 | 3.56 Million USD | 106.43% |
| 2009 | 1.72 Million USD | -38.42% |
| 2008 | 2.8 Million USD | -63.22% |
| 2007 | 7.62 Million USD | 132.59% |
| 2006 | 3.27 Million USD | 1030.0% |
| 2005 | 290 Thousand USD | -72.46% |
| 2004 | 1.05 Million USD | -10.31% |
| 2003 | 1.17 Million USD | -5.93% |
| 2002 | 1.24 Million USD | -65.52% |
| 2001 | 3.62 Million USD | -67.86% |
| 2000 | 11.26 Million USD | 23.76% |
| 1999 | 9.1 Million USD | 7.06% |
| 1998 | 8.5 Million USD | -4.49% |
| 1997 | 8.9 Million USD | 36.92% |
| 1996 | 6.5 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 29 Thousand USD | 113.3% |
| 2024 Q2 | 436 Thousand USD | 1403.45% |
| 2023 Q3 | -29.26 Million USD | -11795.12% |
| 2023 FY | -795.99 Thousand USD | -192.65% |
| 2023 Q2 | -246 Thousand USD | -6.96% |
| 2023 Q4 | -218 Thousand USD | 99.26% |
| 2023 Q1 | -230 Thousand USD | -82.54% |
| 2022 Q1 | -75 Thousand USD | -109.21% |
| 2022 FY | -272 Thousand USD | -144.59% |
| 2022 Q4 | -126 Thousand USD | 99.48% |
| 2022 Q3 | -24.3 Million USD | -16897.2% |
| 2022 Q2 | -143 Thousand USD | -90.67% |
| 2021 Q2 | -21.83 Million USD | -4.07% |
| 2021 Q3 | -18.41 Million USD | 15.63% |
| 2021 Q4 | 814 Thousand USD | 104.42% |
| 2021 Q1 | -20.97 Million USD | -42.29% |
| 2021 FY | 610 Thousand USD | 101.22% |
| 2020 Q4 | -14.74 Million USD | -9.16% |
| 2020 Q2 | -10.8 Million USD | -64.16% |
| 2020 Q1 | -6.58 Million USD | 72.53% |
| 2020 FY | -49.79 Million USD | 1.99% |
| 2020 Q3 | -13.5 Million USD | -25.02% |
| 2019 Q4 | -23.95 Million USD | -118.18% |
| 2019 Q3 | -10.97 Million USD | -9.42% |
| 2019 FY | -50.81 Million USD | -335.89% |
| 2019 Q2 | -10.03 Million USD | -148.71% |
| 2019 Q1 | -4.03 Million USD | -9.2% |
| 2018 Q1 | -1.56 Million USD | 11.8% |
| 2018 Q3 | -1.78 Million USD | 20.04% |
| 2018 FY | -11.65 Million USD | -58.13% |
| 2018 Q4 | -3.69 Million USD | -106.6% |
| 2018 Q2 | -2.23 Million USD | -42.51% |
| 2017 Q1 | -2.04 Million USD | 39.45% |
| 2017 FY | -7.37 Million USD | 13.61% |
| 2017 Q4 | -1.77 Million USD | 5.52% |
| 2017 Q3 | -1.88 Million USD | -13.37% |
| 2017 Q2 | -1.66 Million USD | 18.94% |
| 2016 FY | -8.53 Million USD | -131.84% |
| 2016 Q3 | 1.53 Million USD | 144.23% |
| 2016 Q1 | -3.22 Million USD | -28.29% |
| 2016 Q2 | -3.45 Million USD | -7.42% |
| 2016 Q4 | -3.38 Million USD | -321.18% |
| 2015 FY | 26.79 Million USD | 445.86% |
| 2015 Q2 | -2.2 Million USD | -74.6% |
| 2015 Q4 | -2.51 Million USD | -107.66% |
| 2015 Q3 | 32.77 Million USD | 1585.18% |
| 2015 Q1 | -1.26 Million USD | -6.04% |
| 2014 Q3 | -3.18 Million USD | -65.25% |
| 2014 Q4 | -1.19 Million USD | 62.53% |
| 2014 FY | -7.74 Million USD | 1.31% |
| 2014 Q1 | -1.45 Million USD | 29.44% |
| 2014 Q2 | -1.92 Million USD | -32.76% |
| 2013 Q2 | -1.28 Million USD | 36.0% |
| 2013 Q3 | -2.35 Million USD | -83.31% |
| 2013 Q4 | -2.05 Million USD | 12.55% |
| 2013 FY | -7.85 Million USD | 65.06% |
| 2013 Q1 | -2 Million USD | 57.73% |
| 2012 Q2 | 130 Thousand USD | -89.63% |
| 2012 Q3 | 636 Thousand USD | 389.23% |
| 2012 Q4 | -4.73 Million USD | -845.13% |
| 2012 FY | -22.46 Million USD | -1021.62% |
| 2012 Q1 | 1.25 Million USD | 399.6% |
| 2011 Q3 | 220 Thousand USD | -52.38% |
| 2011 Q1 | 1.5 Million USD | 37.07% |
| 2011 Q4 | 251 Thousand USD | 14.09% |
| 2011 Q2 | 462 Thousand USD | -69.3% |
| 2011 FY | 2.43 Million USD | -31.57% |
| 2010 Q3 | -13.18 Million USD | -1416.88% |
| 2010 Q1 | 918 Thousand USD | 51.74% |
| 2010 Q4 | 1.09 Million USD | 108.33% |
| 2010 Q2 | 1 Million USD | 9.04% |
| 2010 FY | 3.56 Million USD | 106.43% |
| 2009 Q4 | 605 Thousand USD | 22.47% |
| 2009 Q2 | 183 Thousand USD | -58.78% |
| 2009 Q1 | 444 Thousand USD | -18.38% |
| 2009 Q3 | 494 Thousand USD | 169.95% |
| 2009 FY | 1.72 Million USD | -38.42% |
| 2008 Q3 | 367 Thousand USD | 85.35% |
| 2008 Q2 | 198 Thousand USD | -88.31% |
| 2008 FY | 2.8 Million USD | -63.22% |
| 2008 Q1 | 1.69 Million USD | -63.86% |
| 2008 Q4 | 544 Thousand USD | 48.23% |
| 2007 Q2 | 889 Thousand USD | -2.95% |
| 2007 Q4 | 4.68 Million USD | 314.78% |
| 2007 Q3 | 1.13 Million USD | 27.11% |
| 2007 FY | 7.62 Million USD | 132.59% |
| 2007 Q1 | 916 Thousand USD | -22.7% |
| 2006 FY | 3.27 Million USD | 1030.0% |
| 2006 Q4 | 1.18 Million USD | 63.9% |
| 2006 Q3 | 723 Thousand USD | -8.02% |
| 2006 Q2 | 786 Thousand USD | 34.82% |
| 2006 Q1 | 583 Thousand USD | 111.4% |
| 2005 FY | 290 Thousand USD | -72.46% |
| 2005 Q4 | -5.11 Million USD | -859.73% |
| 2005 Q3 | 673 Thousand USD | -85.59% |
| 2005 Q2 | 4.67 Million USD | 7816.95% |
| 2005 Q1 | 59 Thousand USD | -82.54% |
| 2004 FY | 1.05 Million USD | -10.31% |
| 2004 Q2 | 366 Thousand USD | 47.58% |
| 2004 Q4 | 338 Thousand USD | 234.65% |
| 2004 Q1 | 248 Thousand USD | 60.0% |
| 2004 Q3 | 101 Thousand USD | -72.4% |
| 2003 Q1 | 36 Thousand USD | -87.71% |
| 2003 FY | 1.17 Million USD | -5.93% |
| 2003 Q4 | 155 Thousand USD | -67.16% |
| 2003 Q3 | 472 Thousand USD | 65.61% |
| 2003 Q2 | 285 Thousand USD | 691.67% |
| 2002 Q2 | 111 Thousand USD | -78.45% |
| 2002 Q3 | 218 Thousand USD | 96.4% |
| 2002 Q4 | 293 Thousand USD | 34.4% |
| 2002 FY | 1.24 Million USD | -65.52% |
| 2002 Q1 | 515 Thousand USD | -17.34% |
| 2001 Q2 | 585 Thousand USD | -67.45% |
| 2001 Q3 | 615 Thousand USD | 5.13% |
| 2001 FY | 3.62 Million USD | -67.86% |
| 2001 Q1 | 1.79 Million USD | -66.25% |
| 2001 Q4 | 623 Thousand USD | 1.3% |
| 2000 Q1 | 1.64 Million USD | -58.83% |
| 2000 Q4 | 5.32 Million USD | 147.79% |
| 2000 Q3 | 2.14 Million USD | 0.37% |
| 2000 Q2 | 2.14 Million USD | 29.99% |
| 2000 FY | 11.26 Million USD | 23.76% |
| 1999 FY | 9.1 Million USD | 7.06% |
| 1999 Q2 | 1.6 Million USD | -11.11% |
| 1999 Q3 | 1.7 Million USD | 6.25% |
| 1999 Q4 | 4 Million USD | 135.29% |
| 1999 Q1 | 1.8 Million USD | -25.0% |
| 1998 FY | 8.5 Million USD | -4.49% |
| 1998 Q2 | 1.7 Million USD | -34.62% |
| 1998 Q3 | 1.8 Million USD | 5.88% |
| 1998 Q4 | 2.4 Million USD | 33.33% |
| 1998 Q1 | 2.6 Million USD | -23.53% |
| 1997 Q3 | 2.6 Million USD | 4.0% |
| 1997 FY | 8.9 Million USD | 36.92% |
| 1997 Q2 | 2.5 Million USD | 525.0% |
| 1997 Q1 | 400 Thousand USD | -71.43% |
| 1997 Q4 | 3.4 Million USD | 30.77% |
| 1996 Q1 | 1.5 Million USD | 0.0% |
| 1996 Q4 | 1.4 Million USD | -22.22% |
| 1996 Q2 | 1.8 Million USD | 20.0% |
| 1996 FY | 6.5 Million USD | 0.0% |
| 1996 Q3 | 1.8 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 424.794% |
| Alkermes plc | 1.37 Billion USD | 108.984% |
| Agenus Inc. | 139.61 Million USD | 188.46% |
| Aptorum Group Limited | -1.11 Million USD | -10979.603% |
| Ardelyx, Inc. | 106.66 Million USD | 215.79% |
| Dyadic International, Inc. | 922.95 Thousand USD | 13481.23% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 686.406% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -70536.514% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -824.573% |
| Novavax, Inc. | 639.93 Million USD | 119.299% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -163.676% |
| Pyxis Oncology, Inc. | -2 Million USD | -6075.15% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -23800.137% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 748.548% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -279394.433% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -23335.104% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -25.745% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 15499.377% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -150513.415% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 191.302% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1669.089% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -27.388% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 108.137% |
| AlloVir, Inc. | -398 Thousand USD | -30930.905% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 151.302% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 29228.066% |
| Bicycle Therapeutics plc | -129.52 Million USD | 4.646% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 103019.167% |
| ChromaDex Corporation | 50.78 Million USD | 343.212% |
| Chimerix, Inc. | 324 Thousand USD | 38218.21% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -296.254% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -59.157% |
| CRISPR Therapeutics AG | 240.95 Million USD | 151.255% |
| Precision BioSciences, Inc. | 40.47 Million USD | 405.157% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -25.814% |
| Fortress Biotech, Inc. | 57.85 Million USD | 313.477% |
| Fortress Biotech, Inc. | 57.85 Million USD | 313.477% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 845.026% |
| ImmuCell Corporation | 4.39 Million USD | 2909.259% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -16.377% |
| Immix Biopharma, Inc. | -5468.00 USD | -2258550.329% |
| Incyte Corporation | 3.44 Billion USD | 103.59% |
| Innoviva, Inc. | 261.06 Million USD | 147.307% |
| IO Biotech, Inc. | -756 Thousand USD | -16236.376% |
| Jaguar Health, Inc. | 7.72 Million USD | 1698.951% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -18499.849% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 203.131% |
| ContextLogic Inc. | 59 Million USD | 309.327% |
| MiMedx Group, Inc. | 266.84 Million USD | 146.283% |
| MEI Pharma, Inc. | 49.32 Million USD | 350.376% |
| NextCure, Inc. | -3.68 Million USD | -3252.416% |
| Onconetix, Inc. | -1.12 Million USD | -10856.958% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -326.343% |
| Opthea Limited | 21.72 Thousand USD | 568714.18% |
| Psyence Biomedical Ltd. | -240.00 USD | -51459483.333% |
| Vaxcyte, Inc. | -75 Million USD | -64.671% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -215339.766% |
| Precigen, Inc. | 106 Thousand USD | 116612.264% |
| Pharming Group N.V. | 220.1 Million USD | 156.111% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 24081.165% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 12340.139% |
| PureTech Health plc | -1.6 Million USD | -7604.492% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 212.509% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 31.92% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -172.483% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -461.709% |
| Acelyrin, Inc. | -115 Thousand USD | -107293.913% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1228663.307% |
| Summit Therapeutics Inc. | -2.05 Million USD | -5924.537% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -21529.247% |
| Senti Biosciences, Inc. | -2.68 Million USD | -4503.168% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 3148.704% |
| Elevation Oncology, Inc. | -39 Thousand USD | -316574.359% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2474.052% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -3032.965% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 523.986% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 24999.798% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -224450.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 218.64% |
| Seer, Inc. | 7.02 Million USD | 1857.549% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2920.991% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 673.233% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -104129.857% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -86084.325% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 20379.639% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 202.514% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 139.373% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2469960.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 4898.096% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -243303.626% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 520.264% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -53134.052% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -25002.236% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1639.969% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -25925.561% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1187428.846% |
| Soligenix, Inc. | 97.31 Thousand USD | 127015.765% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1042.594% |
| Kura Oncology, Inc. | -849 Thousand USD | -14446.879% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -84.047% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -83915.646% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 224.701% |
| Autolus Therapeutics plc | -4.86 Million USD | -2437.559% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 398.417% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -73413.69% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 230.383% |
| GRI Bio, Inc. | 10.84 Million USD | 1239.221% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 4962.35% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1321.699% |
| IGM Biosciences, Inc. | -211.66 Million USD | 41.65% |
| INmune Bio, Inc. | 155 Thousand USD | 79779.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 299.395% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -8099.146% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -18945.761% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -421786.316% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 30822.139% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -6087.525% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -39357.827% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 230.745% |
| Verastem, Inc. | -62 Thousand USD | -199098.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 5171.992% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -47219.157% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 4180.046% |
| Histogen Inc. | 3.76 Million USD | 3376.811% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 21534.832% |
| Surrozen, Inc. | -27.23 Million USD | -353.555% |
| Organovo Holdings, Inc. | -5.38 Million USD | -2191.761% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -10150.232% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -381.549% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 715.914% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -6237425.253% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 2135.846% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -183873.127% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 179.787% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 84807.133% |
| Apollomics, Inc. | 127 Thousand USD | 97346.457% |
| Amarin Corporation plc | 165.54 Million USD | 174.606% |
| Mesoblast Limited | -9.81 Million USD | -1158.309% |
| Turnstone Biologics Corp. | 16.5 Million USD | 848.231% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -11.779% |
| Synaptogenix, Inc. | -6347.00 USD | -1945748.432% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -242062.745% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 176.536% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 107.027% |
| Better Therapeutics, Inc. | -2.72 Million USD | -4425.577% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -10.112% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 136.531% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1082499.93% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1872.891% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -11046.48% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1787.66% |
| Insmed Incorporated | 239.63 Million USD | 151.538% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 3551.733% |
| OmniAb, Inc. | 14.66 Million USD | 942.047% |
| Alector, Inc. | -95.05 Million USD | -29.931% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 198.314% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -184.157% |
| Zai Lab Limited | 170.9 Million USD | 172.265% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 250.84% |
| Aura Biosciences, Inc. | -1.29 Million USD | -9436.911% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 95102.308% |
| Immunic, Inc. | -111 Thousand USD | -111163.964% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 879.002% |
| Veracyte, Inc. | 248.14 Million USD | 149.77% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.233% |
| FibroGen, Inc. | 128.9 Million USD | 195.81% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -21897595.035% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -958.577% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.634% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 31848.843% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 134.756% |
| TG Therapeutics, Inc. | 219.1 Million USD | 156.366% |
| Galecto, Inc. | -830 Thousand USD | -14779.88% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -8817.184% |
| Fortrea Holdings Inc. | 424 Million USD | 129.128% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -43.33% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -21681.834% |
| XBiotech Inc. | -1.74 Million USD | -6981.594% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -11046.48% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -165.764% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -63.507% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 268.253% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 835.006% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 131.746% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -148.762% |
| Vaxxinity, Inc. | -2.23 Million USD | -5428.335% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 137.797% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -990.646% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 605.104% |
| NexImmune, Inc. | -1.02 Million USD | -11949.402% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2287192.593% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1638.094% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.093% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -184710.032% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -3377.978% |
| Ainos, Inc. | -253.73 Thousand USD | -48574.394% |
| Pluri Inc. | 322 Thousand USD | 38454.969% |
| Prothena Corporation plc | -129.2 Million USD | 4.41% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 344.929% |
| Celularity Inc. | 6.75 Million USD | 1928.32% |
| Rallybio Corporation | -150 Thousand USD | -82235.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -278.762% |
| MeiraGTx Holdings plc | 287 Thousand USD | 43132.404% |
| Omeros Corporation | -69.77 Million USD | -76.992% |
| Humacyte, Inc. | -76.55 Million USD | -61.336% |
| Immunocore Holdings plc | 248.39 Million USD | 149.721% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -714.18% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 297.979% |
| Blueprint Medicines Corporation | 236.58 Million USD | 152.203% |
| CalciMedica, Inc. | -58 Thousand USD | -212836.207% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -8560.799% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 525.066% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -4242.581% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -300.139% |
| Pulmatrix, Inc. | -8.22 Million USD | -1402.47% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -10455.812% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -30853.133% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 69.031% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 4549.621% |
| Cytokinetics, Incorporated | -322.59 Million USD | 61.716% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 14425.749% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -36117.889% |
| Vor Biopharma Inc. | -3.49 Million USD | -3436.741% |
| Roivant Sciences Ltd. | 109.23 Million USD | 213.062% |
| Evogene Ltd. | 1.39 Million USD | 8927.949% |
| ProKidney Corp. | -3.16 Million USD | -3797.223% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -181.251% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1901.123% |
| CorMedix Inc. | -205.56 Thousand USD | -59980.657% |
| BioLineRx Ltd. | 1.1 Million USD | 11246.48% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -56.987% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -374151.515% |
| Atai Life Sciences N.V. | -5000.00 USD | -2469960.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -101249.1% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -128548.958% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -8791.505% |
| Sagimet Biosciences Inc. | 2 Million USD | 6275.15% |
| MediciNova, Inc. | 979.7 Thousand USD | 12706.142% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -46.471% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -130514.986% |
| GeoVax Labs, Inc. | -20.72 Million USD | -496.035% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 150.505% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2839.848% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 114.158% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1763.116% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -39739.677% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1029091.667% |
| Absci Corporation | -41.84 Million USD | -195.116% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2469960.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -61.71% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -4918.407% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 157.783% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -13024.655% |
| Allakos Inc. | -6.14 Million USD | -1911.122% |
| Imunon, Inc. | -720 Thousand USD | -17053.075% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -79.0% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 125.952% |
| BioAtla, Inc. | -103.73 Million USD | -19.061% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1082499.93% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -69283.708% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 49.138% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -39611.576% |
| XOMA Corporation | 3.86 Million USD | 3298.731% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -76.219% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 934.818% |
| aTyr Pharma, Inc. | -2.38 Million USD | -5071.817% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1091.196% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -425772.414% |
| Viridian Therapeutics, Inc. | -1 Million USD | -12152.282% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 950023176.923% |
| Akari Therapeutics, Plc | -4000.00 USD | -3087475.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 119.392% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 63529.854% |
| UroGen Pharma Ltd. | 73.35 Million USD | 268.37% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -362.662% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1063863.997% |
| Orgenesis Inc. | -5.72 Million USD | -2057.258% |
| Entera Bio Ltd. | -56 Thousand USD | -220441.071% |
| GH Research PLC | -315 Thousand USD | -39107.302% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -65245.503% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -23424.381% |
| Xencor, Inc. | -85.26 Million USD | -44.855% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -55789.527% |
| Replimune Group, Inc. | -2.65 Million USD | -4551.714% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -12235.054% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 169.445% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 63529.854% |
| Portage Biotech Inc. | -54 Thousand USD | -228609.259% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -130514.986% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -32659.416% |
| OncoCyte Corporation | 413 Thousand USD | 30003.874% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2747463.96% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -55631881.982% |
| Purple Biotech Ltd. | -196 Thousand USD | -62911.735% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1477.152% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1362.554% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1082.418% |
| HilleVax, Inc. | -2.15 Million USD | -5628.34% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -127222.68% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -823033.831% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -18388.473% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -536869.565% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1645255.282% |
| Savara Inc. | -44.26 Million USD | -179.027% |
| Curis, Inc. | 9.81 Million USD | 1358.822% |
| Daré Bioscience, Inc. | 2.76 Million USD | 4559.362% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -98870.254% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -7043.031% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -54067.982% |
| BeiGene, Ltd. | 2.07 Billion USD | 105.941% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -4317.29% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 69.098% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 317.864% |
| Erasca, Inc. | -3.73 Million USD | -3209.298% |
| bluebird bio, Inc. | -4.03 Million USD | -2964.591% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -437574.534% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 106.485% |
| DBV Technologies S.A. | 15.72 Million USD | 885.243% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -437574.534% |
| Moderna, Inc. | 2.15 Billion USD | 105.731% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -13397.596% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1642.631% |
| Molecular Templates, Inc. | 50.39 Million USD | 345.07% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -22941.604% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 192.312% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1884.941% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -213.914% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -11.136% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -3342.113% |
| MacroGenics, Inc. | 50.52 Million USD | 344.43% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1925.303% |
| Prime Medicine, Inc. | -147.9 Million USD | 16.498% |
| Aditxt, Inc. | -111.66 Thousand USD | -110506.305% |
| Adagene Inc. | 18.11 Million USD | 781.904% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 25407.992% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 188.089% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 178.248% |
| SciSparc Ltd. | 2.19 Million USD | 5723.998% |
| Vericel Corporation | 135.57 Million USD | 191.095% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -492945.631% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -398528.236% |
| Generation Bio Co. | -73.91 Million USD | -67.097% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -28161.556% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 326.117% |
| Invivyd, Inc. | -2.02 Million USD | -5989.892% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 58.947% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -119298.094% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 228.158% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 225.654% |
| ADMA Biologics, Inc. | 88.21 Million USD | 239.998% |
| Clene Inc. | 533 Thousand USD | 23271.295% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 612.265% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -12805.225% |
| GeoVax Labs, Inc. | -20.72 Million USD | -496.035% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 6312.425% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -63457.813% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 347.973% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1641.441% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -14673.086% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 248.059% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 169023.022% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 332.314% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 28.688% |
| Trevena, Inc. | 1.45 Million USD | 8588.179% |
| Surrozen, Inc. | -27.23 Million USD | -353.555% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -34886.686% |
| Cingulate Inc. | -582.91 Thousand USD | -21087.028% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -398296.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -526.951% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1631379.524% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -13918.502% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 118.143% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -12400.304% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -219102.371% |
| Kronos Bio, Inc. | 1.37 Million USD | 9101.676% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -130.133% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -42195.548% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -25191.718% |
| ImmunityBio, Inc. | -17.89 Million USD | -590.347% |
| Korro Bio, Inc. | -3.63 Million USD | -3302.287% |
| Kineta, Inc. | 5.43 Million USD | 2373.201% |
| BioVie Inc. | -229.37 Thousand USD | -53742.8% |
| Codexis, Inc. | 57.33 Million USD | 315.41% |
| Celularity Inc. | 6.75 Million USD | 1928.32% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 3177.573% |
| Celcuity Inc. | -142.77 Thousand USD | -86403.656% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 244225.321% |
| Cibus, Inc. | 1.42 Million USD | 8785.162% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -32922.193% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -438.867% |
| IN8bio, Inc. | -2.5 Million USD | -4838.145% |
| Kodiak Sciences Inc. | -25.94 Million USD | -375.982% |
| Annexon, Inc. | -3.26 Million USD | -3680.318% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -5942.221% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -195.908% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 19397.344% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 115.864% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 171.408% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -6400.158% |
| Arcellx, Inc. | 108.27 Million USD | 214.06% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -281.547% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 255.93% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -483.883% |
| Moolec Science SA | -143.3 Thousand USD | -86081.92% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -191.845% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3857.317% |
| Royalty Pharma plc | 1.79 Billion USD | 106.885% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -76.206% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -3419141.417% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 53474.159% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -10.851% |
| Humacyte, Inc. | -76.55 Million USD | -61.336% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -12911.629% |
| 89bio, Inc. | -273 Thousand USD | -45139.194% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -9725.219% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -14464.033% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -100308.943% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 11136.908% |
| Notable Labs, Ltd. | 113 Thousand USD | 109394.69% |
| Liquidia Corporation | 14.6 Million USD | 945.911% |
| Mustang Bio, Inc. | -2.22 Million USD | -5450.697% |
| Immunovant, Inc. | -231 Thousand USD | -53364.502% |
| Quantum-Si incorporated | 488 Thousand USD | 25407.992% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -122.292% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -411576.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 6732.814% |
| Acasti Pharma Inc. | -11 Thousand USD | -1122654.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -60258.133% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -18945.761% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 26.272% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 10985.35% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -32315.486% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -6207.61% |
| PepGen Inc. | -1.18 Million USD | -10330.997% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -97146.457% |
| United Therapeutics Corporation | 2.07 Billion USD | 105.966% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -439.385% |
| Solid Biosciences Inc. | -76.56 Million USD | -61.309% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -149450.15% |
| Immuneering Corporation | -764.13 Thousand USD | -16062.395% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 186480.237% |
| Belite Bio, Inc | -399 Thousand USD | -30853.133% |
| XOMA Corporation | 3.86 Million USD | 3298.731% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -516.405% |
| Bionomics Limited | -434.44 Thousand USD | -28327.502% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -11399.348% |
| uniQure N.V. | 2.21 Million USD | 5675.756% |
| Cassava Sciences, Inc. | -89.42 Million USD | -38.111% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -34.142% |
| Forte Biosciences, Inc. | -9000.00 USD | -1372155.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -14690.778% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -28161.556% |
| Altimmune, Inc. | -65.37 Million USD | -88.921% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 134.114% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -11399.348% |
| Compugen Ltd. | 31.45 Million USD | 492.634% |
| Peak Bio, Inc. | 367.76 Thousand USD | 33681.678% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 603.765% |
| Benitec Biopharma Inc. | 108 Thousand USD | 114454.63% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -158237.179% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -10166.251% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -6678.43% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -103684.034% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -10166.251% |
| Instil Bio, Inc. | -4.75 Million USD | -2496.783% |
| argenx SE | 1.1 Billion USD | 111.142% |
| Immunome, Inc. | -8.9 Million USD | -1286.584% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -6434.55% |
| Verona Pharma plc | -679.62 Thousand USD | -18072.254% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -70473.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -5078.323% |
| CervoMed Inc. | -1.29 Million USD | -9447.033% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -5030.993% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2485.367% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 5098.098% |
| Moolec Science SA | -143.3 Thousand USD | -86081.92% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -30168.118% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -4522.935% |
| AnaptysBio, Inc. | 14.78 Million USD | 935.552% |
| Design Therapeutics, Inc. | -537 Thousand USD | -22898.696% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -28823.419% |
| NeurAxis, Inc. | 2.15 Million USD | 5826.47% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 5855.033% |
| Lumos Pharma, Inc. | 2 Million USD | 6253.612% |
| Achilles Therapeutics plc | -4.73 Million USD | -2510.358% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -70473.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -116770.594% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 490.107% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 14425.749% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -11867.345% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -171.149% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 287316.279% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -14924.696% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -938515.291% |
| Palisade Bio, Inc. | 246 Thousand USD | 50304.472% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -374151.515% |
| Beam Therapeutics Inc. | -59.67 Million USD | -106.97% |
| Neurogene Inc. | -3.26 Million USD | -3686.113% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 188.637% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -3245.152% |
| Sesen Bio, Inc. | 40 Million USD | 408.758% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -41483.502% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2966.845% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1191.062% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 977.152% |
| Athira Pharma, Inc. | -969 Thousand USD | -12645.408% |
| Vaccinex, Inc. | -16 Million USD | -671.701% |
| HCW Biologics Inc. | -574.82 Thousand USD | -21385.359% |
| XOMA Corporation | 3.86 Million USD | 3298.731% |
| Nektar Therapeutics | 53.47 Million USD | 330.942% |
| Arvinas, Inc. | 71.8 Million USD | 272.01% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -47.977% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -96.739% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -38254.969% |
| Rezolute, Inc. | -36 Thousand USD | -342963.889% |
| Clene Inc. | 533 Thousand USD | 23271.295% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -9618513.707% |
| BeyondSpring Inc. | 1.75 Million USD | 7153.284% |
| Synlogic, Inc. | -1.92 Million USD | -6319.075% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -333691.892% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1850.458% |
| Peak Bio, Inc. | 367.76 Thousand USD | 33681.678% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -551.284% |
| Krystal Biotech, Inc. | 47.6 Million USD | 359.433% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 187.534% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2557.771% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -4669.894% |
| MannKind Corporation | 136.19 Million USD | 190.684% |
| Ikena Oncology, Inc. | -50.49 Million USD | -144.599% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 213.499% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2716.488% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -48909.127% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2469960.0% |
| Legend Biotech Corporation | 140.92 Million USD | 187.635% |
| Mural Oncology plc | -2.56 Million USD | -4711.18% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -22314.338% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -123403.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 695.08% |
| REGENXBIO Inc. | 53.02 Million USD | 332.897% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -2205.471% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -64099.09% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -7030.658% |
| Vaxart, Inc. | -60.76 Million USD | -103.254% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -46898.63% |
| Cellectis S.A. | 18 Thousand USD | 686227.778% |
| Longeveron Inc. | 221 Thousand USD | 55983.71% |
| Repare Therapeutics Inc. | -80.07 Million USD | -54.244% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 111.3% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -9444.281% |
| Revolution Medicines, Inc. | -399.66 Million USD | 69.098% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -352765.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 252146.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.435% |
| Denali Therapeutics Inc. | -93.34 Million USD | -32.308% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -492945.631% |
| Veru Inc. | 7.56 Million USD | 1732.358% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -81690.066% |
| Cingulate Inc. | -582.91 Thousand USD | -21087.028% |
| Passage Bio, Inc. | -3.72 Million USD | -3219.081% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1025331.75% |
| Exicure, Inc. | -1.42 Million USD | -8579.058% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -32146.214% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 4669.108% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -23989.921% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 281.286% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -82451.619% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -108.599% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 31686.445% |
| OmniAb, Inc. | 14.66 Million USD | 942.047% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 717.731% |
| Lipocine Inc. | -2.85 Million USD | -4232.195% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -6601.194% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -2064.82% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -8099.146% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 263.98% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -189904.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 246.511% |
| Ocugen, Inc. | -33.53 Million USD | -268.259% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3805.851% |
| Q32 Bio Inc. | 578 Thousand USD | 21467.301% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -46504.906% |
| Alumis Inc. Common Stock | -1.28 Million USD | -9518.614% |
| Equillium, Inc. | 35.95 Million USD | 443.465% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -7135.091% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 24767.102% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2987393.953% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -47584.556% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 29316.819% |
| Dominari Holdings Inc. | 2.03 Million USD | 6157.038% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -67214.725% |
| vTv Therapeutics Inc. | -13.59 Million USD | -808.444% |
| Bio-Techne Corporation | 773.07 Million USD | 115.976% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 813.107% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 126.803% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -10464.842% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -415.025% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1155.852% |
| Nkarta, Inc. | -5.86 Million USD | -2004.328% |
| BioCardia, Inc. | -7.24 Million USD | -1603.725% |
| Iterum Therapeutics plc | -1.75 Million USD | -6957.314% |